University of Chicago gastroenterologist David T. Rubin, MD, and colleagues attended visits for 23 gastroenterologists examining 68 patients in the United States and Europe with moderate to severe ulcerative colitis. Researchers then conducted separate patient and provider follow-up interviews and analyzed results using sociolinguistic methods.
Here’s what they found.
1. In Europe and the United States, a majority of patients and providers did not discuss how ulcerative colitis would impact quality of life during visits.
2. In the United States, complete patient-physician alignment concerning quality of life was present in 40 percent of cases.
3. There was a variation in treatment goals between gastroenterologists and patients. Only 3 percent of U.S. patients said inflammation absence was a desired goal against 25 percent of gastroenterologists. However, gastroenterologists didn’t always convey that goal during visits.
4. Physicians followed guidelines and framed biological therapies as being suitable for patients. However, many patients, despite the therapy being more aligned with their stated goals, considered biological therapy an option for more severe diseases than theirs.
Researchers concluded, “Alignment between patients and physicians on ulcerative colitis QoL impact, treatment goals and requirement of advanced therapies is poor. New tools are needed to cover this gap.”
More articles on gastroenterology:
Adrienne Wilson Liver Cancer Association awards Dr. Amit Singal the Blue Faery Award: 4 insights
GI leader to know: Dr. Seth Gross of NYU Langone Medical Center
Pfizer awards Dr. Declan McCole $150k grant for IBD research: 4 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
